A new study identifies a novel treatment strategy that preserved neuromuscular synapses in a mouse model of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
A new study identifies a novel treatment strategy that preserved neuromuscular synapses in a mouse model of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.